This company seems to have been delisted
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
KemPharm
KMPH
$7.80
Share price
-0.34%
Change (1 day)
6.09%
Change (1 year)
Categories
KemPharm (KMPH) - Net assets
Net assets on the balance sheet as of December 2022 : S$0.11 Billion
According to KemPharm's latest financial reports the company has S$0.11 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
KemPharm - Net assets on balance sheet (from 2014 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $S$0.11 B | -33.06% |
| 2021-12-31 | $S$0.17 B | -295.6% |
| 2020-12-31 | $-S$87.86 Million | -12.47% |
| 2019-12-31 | $-S$0.11 Billion | 10.38% |
| 2018-12-31 | $-S$90.94 Million | 18.21% |
| 2017-12-31 | $-S$76.93 Million | 184.3% |
| 2016-12-31 | $-S$27.06 Million | 89% |
| 2015-12-31 | $-S$14.32 Million | -55.42% |
| 2014-12-31 | $-S$32.12 Million | 4.44% |
| 2013-12-31 | $-S$30.75 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | S$5.49 B | 4,670.89% | 🇮🇪 Ireland |
 | -S$29.42 Million | -125.54% | 🇺🇸 USA |
 | S$0.23 B | 104.58% | Cayman Islands |
 | S$0.57 B | 399.41% | 🇺🇸 USA |